EUVIMEDEUVIMED entdecken
Crossref

Identification of Methionine Metabolism‐Driven Heterogeneous Subtypes in Colorectal Cancer and Their Associated Immune Microenvironment

Junhao Zhou, Wanhua Deng, Manzhao Ouyang

Asia-Pacific Journal of Clinical Oncology · 28.07.2026

DOI: 10.1111/ajco.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 28.07.2026. Verfasst von Junhao Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), …. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Tumor heterogeneity, driven by metabolic reprogramming, challenges colorectal cancer (CRC) treatment. Methionine metabolism is crucial for tumor progression, but its role in CRC heterogeneity and the tumor immune microenvironment (TIME) requires systematic investigation.

Methods

A systematic evaluation of 101 combinations of machine learning and statistical algorithms was conducted within a 10‐fold cross‐validation framework to develop and validate the optimal model, termed the methionine metabolism‐related risk score (MMRS). The Cancer Genome Atlas‐Colon Adenocarcinoma (TCGA‐COAD) dataset served as the training cohort, while two independent Gene Expression Omnibus (GEO) cohorts (GSE39582 and GSE17536) were employed for external validation. Immune infiltration was assessed using the microenvironment cell populations‐counter (MCP‐counter) algorithm. Model discrimination was evaluated using time‐dependent receiver operating characteristic (ROC) analysis, with the area under the curve (AUC) calculated at 1, 3, and 5 years across all cohorts.

Results

Methionine metabolism‐high (MMH) and metabolism‐low (MML) subtypes were defined via unsupervised clustering. The MMH subtype exhibited significantly poorer overall survival and an immunosuppressive TIME. From subtype‐associated differentially expressed genes (DEGs), 41 prognostic genes were identified. The optimal model (StepCox[both] + plsRcox) formed the MMRS, which effectively stratified patients into high‐ and low‐risk groups with significantly different survival across all cohorts (all p < 0.05). Core signature genes ( MID2, KIF7, GSR ) were consistently selected. The high‐risk group showed depleted antitumor immunity (e.g., fewer CD8+ T and NK cells) and a stroma‐rich phenotype with enrichment of cancer‐associated fibroblasts, underpinned by oxidative stress and alterations in energy metabolism pathways. Time‐dependent ROC analysis confirmed the discriminative capacity of the MMRS, with 5‐year AUCs of 0.803 (TCGA‐COAD), 0.632 (GSE39582), and 0.608 (GSE17536), respectively, further supporting its prognostic accuracy across independent patient populations.

Conclusion

Methionine metabolism heterogeneity is a key determinant of prognosis and immune contexture in CRC. The MMRS is a prognostic signature that effectively stratifies CRC patients by risk, though its clinical utility as a predictive biomarker for treatment selection requires prospective validation.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancercomparative model selectionmachine learningmethionine metabolismprognostic signaturetumor heterogeneitytumor microenvironment

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Shunde, Foshan, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Jianhe People's Hospital, Qiandongnan Miao and Dong Autonomous Prefecture, Kaili City, China.

Zitieren

APA

Zhou, J., Deng, W., & Ouyang, M. (2026). Identification of Methionine Metabolism‐Driven Heterogeneous Subtypes in Colorectal Cancer and Their Associated Immune Microenvironment. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70147

Vancouver

Zhou J, Deng W, Ouyang M. Identification of Methionine Metabolism‐Driven Heterogeneous Subtypes in Colorectal Cancer and Their Associated Immune Microenvironment. Asia-Pacific Journal of Clinical Oncology. 2026. doi:10.1111/ajco.70147

BibTeX
@article{Zhou2026,
  author = {Zhou, Junhao and Deng, Wanhua and Ouyang, Manzhao},
  title = {Identification of Methionine Metabolism‐Driven Heterogeneous Subtypes in Colorectal Cancer and Their Associated Immune Microenvironment},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1111/ajco.70147}
}
Kostenlos starten →